+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Limbal Stem Cell"

From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Limbal Stem Cell (LSC) market is a subset of the larger stem cell market. LSCs are a type of stem cell found in the cornea of the eye, and are used to treat a variety of eye diseases, such as corneal blindness, limbal stem cell deficiency, and ocular surface diseases. LSCs are harvested from donor tissue, and then cultured and expanded in the laboratory. The resulting cells are then transplanted into the patient's eye to restore vision. The LSC market is growing rapidly, driven by increasing demand for treatments for eye diseases, as well as advances in stem cell technology. The market is expected to continue to grow in the coming years, as more treatments become available and the technology continues to improve. Some of the major players in the LSC market include Advanced Cell Technology, BioTime, Cell Cure Neurosciences, CornealGen, and Ocata Therapeutics. Show Less Read more